These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 32824215)

  • 1.
    Sandhof CA; Hoppe SO; Tittelmeier J; Nussbaum-Krammer C
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the spreading and toxicity of prion-like proteins using the metazoan model organism C. elegans.
    Nussbaum-Krammer CI; Neto MF; Brielmann RM; Pedersen JS; Morimoto RI
    J Vis Exp; 2015 Jan; (95):52321. PubMed ID: 25591151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spreading of a prion domain from cell-to-cell by vesicular transport in Caenorhabditis elegans.
    Nussbaum-Krammer CI; Park KW; Li L; Melki R; Morimoto RI
    PLoS Genet; 2013 Mar; 9(3):e1003351. PubMed ID: 23555277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
    Nonaka T
    Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prions and prion-like pathogens in neurodegenerative disorders.
    Peggion C; Sorgato MC; Bertoli A
    Pathogens; 2014 Feb; 3(1):149-63. PubMed ID: 25437612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster.
    Donnelly KM; Pearce MMP
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative diseases: expanding the prion concept.
    Walker LC; Jucker M
    Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
    Pineau H; Sim V
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions, prion-like prionoids, and neurodegenerative disorders.
    Verma A
    Ann Indian Acad Neurol; 2016; 19(2):169-74. PubMed ID: 27293325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.
    Marciniuk K; Taschuk R; Napper S
    Clin Dev Immunol; 2013; 2013():473706. PubMed ID: 24228054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.